Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Driving better diagnostic discovery for patients with Rebecca Middleton, vice chair of the participant panel at Genomics England The impact of genomics on global healthcare is one to watch.… In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Enabling faster diagnosis of rare diseases: Interview with HBA Support’s Rebecca Middleton As global research and the understanding of genomics grows… In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
The future of thalassemia care The impact of genomics on global healthcare is one to watch.… In-vitro diagnostics | Next Generation Sequencing (NGS) | IVD Gateway | Next Generation Sequencing (NGS)
Building a market access blueprint for lung cancer diagnostics in Asia-Pacific Lung cancer is the leading cause of cancer mortality in the… Cancer diagnostics | Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Launching a new value proposition for core lab solutions An IVD multinational company is preparing to roll out a new… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | Asia | Europe | Global | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway
Uncovering opportunities faster with IVD Size & Share Plus In dynamic market segments such as infectious disease… In-vitro diagnostics | Global | IVD Gateway | Size and Share Plus
Support strategic market planning with IVD Size & Share Plus Enable winning go-to-market strategies by tracking… In-vitro diagnostics | Uncategorised | Global | IVD Gateway | Size and Share Plus
How Indonesia’s healthcare transformation will impact its IVD market Indonesia’s in-vitro diagnostics (IVD) market will recover… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
How inflation will impact Brazil’s IVD market Brazil’s in-vitro diagnostics (IVD) market will recover in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Uncategorised | Americas
Testing times: opportunities for IVD companies in 2023 Growth opportunities from covid-19 have helped fuel rapid… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Americas | Asia | Europe | Global | Middle East & Africa
APAC IVD market to shrink by 2026 as demand for covid-19 testing cools further The Asia-Pacific (APAC) in-vitro diagnostics (IVD) market… In-vitro diagnostics | Asia | IVD Gateway
Infectious Diseases Trend Monitor: India The Indian government is increasing its investment on… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now